Lilly Reports Solid First-Quarter 2019 Financial Results, Updates 2019 Guidance to Reflect Disposition of Elanco Animal Health

Go back to Lilly Reports Solid First-Quarter 2019 Financial Results, Updates 2019 Guidance to Reflect Disposition of Elanco Animal Health

Eli Lilly & Co. (LLY) Tops Q1 EPS by 1c, Offers Guidance

April 30, 2019 6:26 AM EDT

Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.33, $0.01 better than the analyst estimate of $1.32. Revenue for the quarter came in at $5.09 billion versus the consensus estimate of $5.22 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2019 EPS of $5.60-$5.70, versus the... More